Oriol Arpi

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 07, 2023

The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer.

The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer.

Journal: Scientific reports

Published: April 05, 2023

CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer.

CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer.

Journal: Journal of clinical medicine

Published: January 14, 2022

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 16, 2020

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 16, 2020

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.

Journal: Cancers

Published: March 30, 2020

Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.

Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.

Journal: Molecular cancer therapeutics

Published: December 30, 2019

HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer.

HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer.

Journal: Molecular cancer therapeutics

Published: May 02, 2019

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.

Journal: Oncoimmunology

Published: December 19, 2018

High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer.

High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer.

Journal: Cancer immunology research

Published: December 13, 2018

Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models.

Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models.

Journal: Molecular cancer research : MCR

Published: August 31, 2018

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Journal: Oncoimmunology

Published: August 23, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026